[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100454714":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":18,"centralContacts":23,"locations":33,"responsibleParty":52,"collaborators":10,"id":54,"slug":10,"hasResults":55,"nctId":56,"briefTitle":57,"officialTitle":57,"acronym":10,"eligibilityCriteria":58,"healthyVolunteers":55,"sex":59,"minAge":60,"maxAge":10,"enrollmentInfo":61,"targetDuration":10,"studyType":64,"phases":10,"briefSummary":65,"conditions":66,"keywords":68,"overallStatus":35,"whyStopped":10,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":74,"completionDateStruct":76,"leadSponsor":78,"locationsCount":79},{"fullName":5,"class":6},"Can-Am HIFU Inc.","OTHER",[8],{"label":9,"type":10,"description":10,"interventionNames":11},"Rezum procedure",null,[12],"Procedure: Rezum",[14],{"type":15,"name":16,"description":16,"armGroupLabels":17,"otherNames":10},"PROCEDURE","Rezum",[9],[19],{"name":20,"affiliation":21,"role":22},"Dean Elterman","University Health Network, Toronto","PRINCIPAL_INVESTIGATOR",[24,30],{"name":25,"role":26,"phone":27,"phoneExt":28,"email":29},"Iris Chan","CONTACT","416-603-5800","5033","iris.chan2@uhn.ca",{"name":20,"role":26,"phone":31,"phoneExt":10,"email":32},"141660358005033","dean.elterman@uhn.ca",[34],{"facility":20,"status":35,"city":36,"state":37,"zip":38,"country":39,"cosmosGeoPoint":40,"geoPoint":45,"contacts":46},"RECRUITING","Toronto","Ontario","M5T 2S8","Canada",{"type":41,"coordinates":42},"Point",[43,44],-79.39864,43.70643,{"lat":44,"lon":43},[47,49,51],{"name":20,"role":26,"phone":48,"phoneExt":28,"email":32},"4166035800",{"name":25,"role":26,"phone":48,"phoneExt":50,"email":32},"Elterman",{"name":20,"role":22,"phone":10,"phoneExt":10,"email":10},{"type":22,"investigatorFullName":20,"investigatorTitle":53,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Urologist","100454714",false,"NCT05201131","Canadian Cohort of Convective Thermal Therapy Using Rezūm System in Benign Prostatic Hyperplasia (BPH).","Inclusion Criteria:\n\n* Male subjects of ≥ 18 years of age.\n* Primary diagnosis of Benign Prostate Hypertrophy (BPH).\n* Candidate for Rezūm therapy as per clinical decision of Investigator.\n* Willing and able to accurately complete the required questionnaires.\n* Willing and able to provide signed and dated informed consent\n\nExclusion Criteria:\n\n* Characteristics indicating a poor compliance with study protocol requirements.\n* Disease or other health condition that is not suitable for this study.\n* Unable or unwilling to provide signed informed consent.","MALE","18 Years",{"count":62,"type":63},50,"ESTIMATED","OBSERVATIONAL","To document the clinical outcome of Rezūm therapy for BPH patient in Canadian cohort.",[67],"Urologic Diseases",[69],"benigh prostate hypertrophy","2022-01-07",{"date":72,"type":73},"2022-01-21","ACTUAL",{"date":75,"type":73},"2019-10-07",{"date":77,"type":63},"2026-12-31",{"name":5,"class":6},1]